Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands
Publication year
2022Source
Frontiers in Immunology, 13, (2022), article 734256ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Laboratory Medicine
Journal title
Frontiers in Immunology
Volume
vol. 13
Subject
Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Laboratory Medicine - Radboud University Medical Center; Radboud University Medical CenterThis item appears in the following Collection(s)
- Academic publications [245131]
- Electronic publications [132449]
- Faculty of Medical Sciences [93207]
- Open Access publications [106006]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.